Regulatory T Cells in Acute Respiratory Distress Syndrome: Current Status and Potential for Future Immunotherapies-Reference-Cited by-同舟云学术

Regulatory T Cells in Acute Respiratory Distress Syndrome: Current Status and Potential for Future Immunotherapies

Published:2024-07-22 Issue:4 Volume:141 Page:755-764
ISSN:0003-3022
Container-title:Anesthesiology
language:en
Short-container-title:

Author:

Halter Sébastien¹,Rosenzwajg Michelle²,Klatzmann David³,Sitbon Alexandre⁴,Monsel Antoine⁵^ORCID

Affiliation:

1. 1Multidisciplinary Intensive Care Unit, Department of Anesthesiology and Critical Care, La Pitié–Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris Sorbonne University, Paris, France; Sorbonne University–INSERM UMRS_959, Immunology–Immunopathology–Immunotherapy (I3), Paris, France; and Biotherapy (CIC-BTi), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

2. 2Sorbonne University–INSERM UMRS_959, Immunology–Immunopathology–Immunotherapy (I3), Paris, France; Biotherapy (CIC-BTi), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

3. 3Sorbonne University–INSERM UMRS_959, Immunology–Immunopathology–Immunotherapy (I3), Paris, France; Biotherapy (CIC-BTi), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

4. 4Multidisciplinary Intensive Care Unit, Department of Anesthesiology and Critical Care, La Pitié–Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris Sorbonne University, Paris, France; Sorbonne University, INSERM, Centre de Recherche de Saint-Antoine, UMRS-938, Paris, France.

5. 5Multidisciplinary Intensive Care Unit, Department of Anesthesiology and Critical Care, La Pitié–Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris Sorbonne University, Paris, France; Sorbonne University–INSERM UMRS_959, Immunology–Immunopathology–Immunotherapy (I3), 75013 Paris, France; Biotherapy (CIC-BTi), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Abstract

This Clinical Focus Review aims to comprehensively assess current knowledge regarding the biology of Tregs and their role in COVID-19–associated and nonassociated ARDS, focusing on their involvement during the acute and resolution phases of the disease. The authors discuss the potential of Treg-based cell therapies and drugs targeting Tregs as therapeutic strategies in ARDS.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

https://pubs.asahq.org/anesthesiology/article-pdf/141/4/755/713209/20241000.0-00024.pdf

Reference68 articles.

1. Acute respiratory distress syndrome: The Berlin Definition.;Ranieri;JAMA,2012

2. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries.;Bellani;JAMA,2016

3. A new global definition of acute respiratory distress syndrome.;Matthay;Am J Respir Crit Care Med,2024

4. Definition and epidemiology of acute respiratory distress syndrome.;Rezoagli;Ann Transl Med,2017

5. The acute respiratory distress syndrome.;Matthay;J Clin Invest,2012